Effects of basic fibroblast growth factor (FGF-2) on proliferation of human skin fibroblasts in type II diabetes mellitus

Experimental and Clinical Endocrinology and Diabetes

Volumn 110, Issue 4, 2002, Pages 176-181

  Grazul Bilska, A T ^a   Luthra, G ^a   Reynolds, L P ^a   Bilski, J J ^a   Johnson, M L ^a   Adbullah, S A ^a   Redmer, D A ^a   Abdullah, K M ^a  

^a NORTH DAKOTA STATE UNIVERSITY   (United States)

Author keywords

CAMP; Diabetes mellitus; FGF 2; Fibroblasts; Wound healing

Indexed keywords

BASIC FIBROBLAST GROWTH FACTOR; CYCLIC AMP; FIBROBLAST GROWTH FACTOR 2;

ARTICLE; CELL PROLIFERATION; DIABETIC FOOT; EXTRACELLULAR MATRIX; HUMAN; HUMAN CELL; HUMAN TISSUE; MICROVASCULATURE; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; PROTEIN SYNTHESIS; RADIOIMMUNOASSAY; RECEPTOR DOWN REGULATION; RECEPTOR GENE; SKIN FIBROBLAST; WOUND HEALING; CELL CULTURE; CELL DIVISION; CONTROL GROUP; DRUG EFFECT; FIBROBLAST; METABOLISM; PATHOLOGY; SKIN;

CELL DIVISION; CELLS, CULTURED; CONTROL GROUPS; CYCLIC AMP; DIABETES MELLITUS, NON-INSULIN-DEPENDENT; FIBROBLAST GROWTH FACTOR 2; FIBROBLASTS; HUMAN; SKIN; SUPPORT, NON-U.S. GOV'T; DIABETES MELLITUS, TYPE 2; HUMANS;

EID: 0036016567     PISSN: 09477349     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2002-32149     Document Type: Article

References (68)

1. Cell-to-cell communication and expression of gap junctional proteins in human diabetic and non-diabetic fibroblasts: Effects of basic fibroblast growth factor
2. Angiogenesis in wound healing
3. Fibroblast growth factors
4. The heparin binding growth factor family of protein
5. The effect of cyclic adenosine monophosphate on the mitogenactivated protein kinase pathway depends on both the cell type and the type of tyrosine kinase-receptor
6. Identification of mitogen-activated protein (MAP) kinase in normal human osteoblastic and bone marrow stromal cells: Attenuation of MAP kinase activation by cAMP, parathyroid hormone and forskolin
7. cAMP-dependent protein kinase inhibits the mitogenic action of vascular endothelial growth factor and fibroblast growth factor in capillary endothelial cells by blocking Raf activation
8. MAP kinase abnormalities in hyperproliferative cultured fibroblasts from psoriatic skin
9. Mitogenesis in wound-healing cells in diabetic rats
10. Diabetes mellitus and aging: Diminished plating efficiency of cultured human fibroblasts
11. Studies of wound healing in experimental diabetes mellitus
12. Wound healing and the diabetic patient
13. Localization of a fibroblast growth factor and its effect alone and with hydrocortisone on 3T3 cell growth
14. Heparin protects basic and acidic FGF from inactivation
15. The use of growth factors in clinical practice
16. Proliferation and progesterone production of ovine luteal cells throughout the estrous cycle: Effects of fibroblast growth factors (FGF), luteinizing hormone (LH) and fetal bovine serum (FBS)
17. Gap junctional intercellular communication of bovine luteal cells from several stages of the estrous cycle: Effects of cyclic adenosine 3′,5′-monophosphate
18. The role of growth factors in wound healing
19. PDGF and FGF stimulate wound healing in the genetically diabetic mouse
20. Topical insulin in wound healing: A randomised, double-blind, placebo-controlled trial
21. Stimulation of granulation tissue formation by platelet-derived growth factor in normal and diabetic rats
22. The antiproliferative effect of a transferrin-toxin on human retinal pigment epithelial cells and rabbit fibroblasts
23. Impaired proliferation and increased L-lactate production of dermal fibroblasts in the GK-rat, a spontaneous model of non-insulin dependent diabetes mellitus
24. Inhibited proliferation of fibroblasts derived from chronic diabetic wounds and normal dermal fibroblasts treated with high glucose is associated with increased formation of 1-lactate
25. Fibroblasts derived from human chronic diabetic wounds have a decreased proliferation rate, which is recovered by the addition of heparin
26. Mitogenic activation of the transferrin receptor gene promoter is modulated by inhibitors of tyrosine kinases and tyrosine phosphatases
27. Hormone-independent activation of adenylate cyclase in large steroidogenic ovine luteal cells does not result in increased progesterone secretion
28. Mitogenic growth factors regulate differentially early gene mRNA expression: A study on two clones of 3T3 fibroblasts
29. The pathobiology of diabetes mellitus: Implications for surgeons
30. Effects of ferrous iron and transferrin on cell proliferation of human diploid fibroblasts in serum-free culture
31. Cyclic AMP inhibits activation of mitogen-activated protein kinase and cell proliferation in response to growth factors in cultured rat cortical astrocytes
32. Therapy with growth factors
33. Cultured fibroblasts from chronic diabetic wounds on the lower extremity (noninsulin-dependent diabetes mellitus) show disturbed proliferation
34. The ins and outs of fibroblast growth factors
35. Preclinical and clinical studies with recombinant human basic fibroblast growth factor
36. cAMP-mediated growth inhibition in fibroblasts is not mediated via mitogen-activated protein (MAP)kinase (ERK) inhibition. cAMP-dependent protein kinase induces a temporal shift in growth factor-stimulated MAP kinases
37. Acidic fibroblast growth factor accelerates dermal would healing in diabetic mice
38. Diabetes and wound healing
39. Wound healing in diabetes mellitus
40. Arachidonic acid mediates calcium influx induced by basic fibroblast growth factor in Balb-c 3T3 fibroblasts
41. Basic fibroblast growth factor mediates angiogenic activity in early surgical wounds
42. Glucose modulates growth of gingival fibroblasts and periodontal ligament cells: Correlation with expression of basic fibroblast growth factor
43. Effects of a collagen matrix containing basic fibroblast growth factor on wound contraction
44. Application of basic fibroblast growth factor may reverse diabetic wound healing impairment
45. Involvement of protein kinase A in fibroblast growth factor-2-activated transcription
46. The effects of recombinant basic fibroblast growth factor (bFGF) in fibrin adhesive vehicle on the healing of ischaemic and normal incisional skin wounds
47. Potential role of fibroblast growth factor in enhancement of fracture healing
48. Effect of topical basic fibroblast growth factor on the healing of chronic diabetic neuropathic ulcer of the foot. A pilot, randomized, double-blind, placebo-controlled study
49. The safety and effect of topically applied recombinant basic fibroblast growth factor on the healing of chronic pressure sores
50. Abnormalities in proliferation and protein synthesis in skin fibroblast cultures from patients with diabetes mellitus
51. Cell biology of wound healing
52. Fibroblast migration and proliferation during in vitro wound healing. A quantitative comparison between various growth factors and a low molecular weight blood dialysate used in the clinic to normalize impaired wound healing
53. Increasing cAMP attenuates activation of mitogen-activated protein kinase
54. Diabetes and wound healing
55. Identification and concerted function of two receptor binding surfaces on basic fibroblast growth factor required for mitogenesis
56. The role of growth factors in wound healing
57. Growth-stimulatory actions of insulin in vitro and in vivo
58. Impaired wound repair and delayed angiogenesis in aged mice
59. Mechanism of acceleration of wound healing by basic fibroblast growth factor in genetically diabetic mice
60. Restrictive replicative life span of diabetic fibroblasts in vitro: Its relation to microangiopathy
61. Transferrin and transferrin receptor expression in intraocular proliferative disease. APAAP-immunolabeling of retinal membranes and ELISA for vitreal transferrin
62. Differentiation of PC12 cells in response to a cAMP analogue is accompanied by sustained activation of mitogen-activated protein kinase. Comparison with the effects of insulin, growth factors and phorbol esters